Drug: HZT-501: chronic pain clinical trials
Registry records that list "Drug: HZT-501" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
3
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment NCT00984815 | Completed | Phase 3 | United States | Amgen | 2009-09 |
| Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216) NCT00613106 | Completed | Phase 3 | United States | Amgen | 2007-09 |
| Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers NCT00450658 | Completed | Phase 3 | Amgen | 2007-03 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.